These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3941770)

  • 41. Electromyographic studies in myotonia congenita.
    Kirby JF; Kraft GH
    Arch Phys Med Rehabil; 1973 Feb; 54(2):47-50 passim. PubMed ID: 4692633
    [No Abstract]   [Full Text] [Related]  

  • 42. Ion content, potassium efflux and cable properties of myotonic, human, external-intercostal muscle.
    Lipicky RJ; Bryant SH
    Trans Am Neurol Assoc; 1971; 96():34-8. PubMed ID: 5159127
    [No Abstract]   [Full Text] [Related]  

  • 43. Evidence of myotonic origin of type 2B muscle fibre deficiency in myotonia and paramyotonia congenita.
    Heene R
    J Neurol Sci; 1986 Dec; 76(2-3):357-9. PubMed ID: 3794755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of myotonic discharges in myotonia congenita and dystrophia myotonica].
    Ricker K; Meinck HM
    Z Neurol; 1972; 201(1):62-72. PubMed ID: 4112385
    [No Abstract]   [Full Text] [Related]  

  • 45. A case of paramyotonia congenita without periodic paralysis: electrophysiological and molecular genetic studies.
    Park JH; Lee YW; Park SA; Lee TK; Rho HJ; Sung KB
    Neurologist; 2010 May; 16(3):203-5. PubMed ID: 20445432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different effectiveness of tocainide and hydrochlorothiazide in paramyotonia congenita with hyperkalemic episodic paralysis.
    Ricker K; Böhlen R; Rohkamm R
    Neurology; 1983 Dec; 33(12):1615-8. PubMed ID: 6417558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
    Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A
    Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.
    Tan SV; Matthews E; Barber M; Burge JA; Rajakulendran S; Fialho D; Sud R; Haworth A; Koltzenburg M; Hanna MG
    Ann Neurol; 2011 Feb; 69(2):328-40. PubMed ID: 21387378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Neurophysiological studies on the temporary paresis in myotonia congenita and dystrophia myotonica].
    Ricker K; Meinch HM; Stumpf H
    Z Neurol; 1973 Apr; 204(2):135-48. PubMed ID: 4121467
    [No Abstract]   [Full Text] [Related]  

  • 50. [A Japanese family with paramyotonia congenita which has a mutation in the muscle sodium channel gene].
    Ochi H; Yamada T; Hara H; Yoshimura T; Kobayashi T
    Rinsho Shinkeigaku; 1995 Aug; 35(8):893-6. PubMed ID: 8665733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A large German kindred with cold-aggravated myotonia and a heterozygous A1481D mutation in the SCN4A gene.
    Schoser BG; Schröder JM; Grimm T; Sternberg D; Kress W
    Muscle Nerve; 2007 May; 35(5):599-606. PubMed ID: 17212350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative efficacy of repetitive nerve stimulation, exercise, and cold in differentiating myotonic disorders.
    Michel P; Sternberg D; Jeannet PY; Dunand M; Thonney F; Kress W; Fontaine B; Fournier E; Kuntzer T
    Muscle Nerve; 2007 Nov; 36(5):643-50. PubMed ID: 17654559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple sclerosis and non-dystrophic myotonias: do they share a common pathophysiology?
    Portaro S; Naro A; Russo M; Bramanti P; Lauria P; D'Aleo G; La Rosa G; Bramanti A; Calabrò RS
    Funct Neurol; 2018; 33(4):194-199. PubMed ID: 30663965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myotonia. An evaluation of the chloride hypothesis.
    Barchi RL
    Arch Neurol; 1975 Mar; 32(3):175-80. PubMed ID: 1119960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial case of myotonia with muscular hypertrophy, weakness corrected by effort and atrophy of type II fibers].
    Pépin B; Haguenau M; Mikol J
    Rev Neurol (Paris); 1975 Apr; 131(4):285-92. PubMed ID: 1224112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation.
    McKay OM; Krishnan AV; Davis M; Kiernan MC
    Clin Neurophysiol; 2006 Sep; 117(9):2064-8. PubMed ID: 16854622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decrement of compound muscle action potential is related to mutation type in myotonia congenita.
    Colding-Jørgensen E; DunØ M; Schwartz M; Vissing J
    Muscle Nerve; 2003 Apr; 27(4):449-55. PubMed ID: 12661046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transient weakness and compound muscle action potential decrement in myotonia congenita.
    Deymeer F; Cakirkaya S; Serdaroğlu P; Schleithoff L; Lehmann-Horn F; Rüdel R; Ozdemir C
    Muscle Nerve; 1998 Oct; 21(10):1334-7. PubMed ID: 9736066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetazolamide-induced weakness in paramyotonia congenita.
    Riggs JE; Griggs RC; Moxley RT
    Ann Intern Med; 1977 Feb; 86(2):169-73. PubMed ID: 835937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The declining electrical response of muscle to repetitive nerve stimulation in myotonia.
    Aminoff MJ; Layzer RB; Satya-Murti S; Faden AI
    Neurology; 1977 Sep; 27(9):812-6. PubMed ID: 561337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.